Statement regarding recent media speculation

RNS Number : 9802F

Smiths Group PLC

31 May 2013

 

Statement regarding recent media speculation

The Board of Smiths Group notes the recent media speculation about Smiths Medical.  Smiths today confirms that it has received a preliminary approach for the Medical division. This approach may or may not lead to a transaction. Discussions are at an early stage and a further announcement will be made as appropriate.

ENDS

Investor Relations

Peter Durman: [phone]

Media Relations

Colin McSeveny: [phone]

Anthony Cardew - Cardew Group: [phone]

Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs around 23,000 people in over 50 countries. For more information visit www.smiths.com

 

END

 

 

MSCABMFTMBAJMAJ